Oncology Nutrition Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 8.90 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Oncology Nutrition Market Analysis
Over the next few years, the oncology nutrition market is expected to grow at an annual rate of 8.9%.
The COVID-19 pandemic turned the spotlight on the oncology nutrition market, though the healthcare systems have been significantly impacted. For instance, the study published by Nutrition and Cancer in May 2021 focused on creating recommendations on the nutritional protocol for the management and prevention of complications during the COVID-19 pandemic for all cancer patients. Patients with cancer are more susceptible to illnesses due to either direct immune system impairment or anticancer medication. Furthermore, as per the article published by the National Library of Medicine in June 2021, the role of nutrition, dietary supplementation with vitamins or minerals, and microbiota in the COVID-19 phase, as well as the value of diet in the susceptibility, prevention, and management of COVID-19 in cancer patients, The COVID-19 pandemic demanded the development of nutritional maintenance and complication control recommendations for all cancer patients, according to the same source. However, the market was gradually stabilizing as COVID-19 cases declined, resulting in the return of normal demand levels for oncology nutrition. Thus, COVID-19 was expected to have a significant impact on the oncology nutrition market over the forecast period.
The major factors contributing to the growth of the oncology nutrition market are the rising prevalence of cancer worldwide and the introduction of new oncology nutrition products. According to a BioMed Central Ltd article published in April 2022, the number of new cancer cases in Germany is expected to rise by 20% by 2030.Additionally, according to the AACR Cancer Progress Report 2022, in the past three years, the number of cancer survivors living in the United States has increased by more than a million, reaching more than 18 million as of January 1, 2022. The use of nutritional products during and after the treatment of cancer gives the ability to fight disease and offers strength and stamina against the treatment's after-effects, which is driving the market's growth.
Furthermore, the awareness provided by the government and private agencies is one of the main fueling factors for market growth. For instance, as per the 2022 update from the American Society of Clinical Oncology (ASCO) Cancer.Net, after cancer treatment is complete, most experts recommend a healthy diet that includes plenty of fruits, vegetables, and whole grains. Furthermore, according to the Agency for Healthcare Research and Quality, the prevalence of malnutrition among adults with cancer is high in October 2021, with estimates ranging from 25% to 80% across patient populations.This increase in malnutrition among cancer patients is expected to increase the demand for oncology nutrition, thus boosting market growth over the forecast period.
Hence, as per the aforementioned factors, the oncology nutrition market is likely to grow over the forecast period. However, the high cost of premium nutrition products for oncology restrains the market's growth.
Oncology Nutrition Market Trends
This section covers the major market trends shaping the Oncology Nutrition Market according to our research experts:
Lung Cancer is Expected to Witness a Healthy Growth Over the Forecast Period
The lung cancer segment is likely to grow during the study period owing to factors such as the high prevalence of lung cancer worldwide, an increase in lung cancer nutritional supplements, and raising awareness of the importance of taking nutritional supplements. For instance, as per Lung Cancer Fact 2022, lung cancer is the leading cause of cancer death worldwide. In the United States, an estimated 236,740 people will be diagnosed with lung cancer in 2022.1 in 16 people were diagnosed with lung cancer in their lifetime-1 in 15 men and 1 in 17 women. As the number of cancer patients rises, since nutrition gives the body the power to fight disease and provides strength and stamina to withstand the side effects of treatment, the need for oncology nutrition is projected to grow over the forecast period.
Furthermore, government initiatives encourage people to consume proper nutrition both during and after cancer treatment.For that purpose, the agencies are relaxing and preparing many regulations relating to the same. For instance, in May 2021, U.S. Senators Susan Collins (R-ME) and Gary Peters (D-MI) introduced the "Medical Nutrition Therapy Act," bipartisan legislation that would expand Medicare Part B to cover medical nutrition therapy (MNT) services for additional conditions, including cancer, prediabetes, eating disorders, malnutrition, gastrointestinal diseases (e.g., celiac disease), cardiovascular disease, HIV/AIDS, and other diseases or conditions that cause unintentional weight loss. Such movements are likely to help people financially and motivate them to be more keen on taking nutritional supplements, thereby boosting the market's growth.
Hence, as per the factors mentioned above, the lung cancer segment is likely to grow in the oncology nutrition market over the forecast period.
North America is Expected to Witness a Healthy Growth Over the Forecast Period
North America is expected to witness growth in the overall oncology nutrition market throughout the forecast period. This is due to factors such as the rising prevalence of cancer and the availability of advanced healthcare infrastructure, among other major factors. For instance, as per the report from the American Cancer Society for 2022, there are estimated to be 1.9 million new cancer cases diagnosed in the United States in 2022. Moreover, government initiatives, product launches, and collaborations in cancer nutrition supplements boost market growth. For instance, the Academy of Nutrition and Dietetics conducted the "2022 Oncology Nutrition Symposium" on June 20, 2022. In the symposium, they discuss the practice of oncology nutrition, which covers research, prevention, treatment, recovery, palliative care, and hospice.
Furthermore, the Canada Cancer Society estimates that there will be 233,900 new cancer cases in Canada in 2022. The increasing incidence of cancer cases in the region of North America is anticipated to boost market growth. Additionally, many certification programs and awareness classes are conducted regionally to educate cancer patients and providers regarding the importance of oncology nutrition. For example, the Oncology Nutrition Institute (ONI) provides evidence-based educational certification and training programs in the field of modern, metabolic, innovative, integrative, and outcomes-based oncology nutrition therapy. Its flagship 250-hour Oncology Nutrition Consulting (ONC) certification program is an intensive training program for qualified nutrition, health, and medical practitioners. Its flagship 250-hour Oncology Nutrition Consulting (ONC) certification program is an intensive training program for qualified nutrition, health, and medical practitioners. Thus, such an increase in cancer cases is expected to increase the demand for oncology nutrition, eventually driving the market.
Hence, as per the factors mentioned above, North America is expected to witness growth over the forecast period.
Oncology Nutrition Industry Overview
The oncology nutrition market is consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well-known, including Abbott Laboratories, Nestle, Fresenius Kabi AG, B. Braun SE, and Hormel Foods Corporation, among others.
Oncology Nutrition Market Leaders
-
Abbott Laboratories
-
Fresenius Kabi AG
-
Hormel Foods Corporation (Hormel Health Labs)
-
Nestlé
-
B. Braun SE
*Disclaimer: Major Players sorted in no particular order
Oncology Nutrition Market News
- July 2022: Nestle launched China's first Foods for Special Medical Purpose (FSMP) for patients suffering from tumor-related conditions, after going through a five-year-long approval process from the Chinese regulator.
- January 2022: Faeth Therapeutics closed a USD 47 million Series A round of private financing led by S2G Ventures, bringing total funding to date to USD 67 million. The money from the financing will be used to move forward with Faeth's clinical trials, which use a combination of nutrient control, drugs, and digital tools to stop cancer from growing.
Oncology Nutrition Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising prevalence of Cancer Worldwide
- 4.2.2 Introduction of New Oncology Nutrition Products
-
4.3 Market Restraints
- 4.3.1 High Cost of Premium Nutrition Products for Oncology
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
5.1 By Cancer Type
- 5.1.1 Head & Neck Cancer
- 5.1.2 Stomach & Gastrointestinal Cancers
- 5.1.3 Blood Cancer
- 5.1.4 Breast Cancer
- 5.1.5 Lung Cancer
- 5.1.6 Other Cancers
-
5.2 By End-User
- 5.2.1 Hospitals
- 5.2.2 Home Care
- 5.2.3 Other End-Users
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Abbott Laboratories
- 6.1.2 Nestle
- 6.1.3 Fresenius Kabi AG
- 6.1.4 B. Braun SE
- 6.1.5 Hormel Foods Corporation
- 6.1.6 Sofina (Danone S.A.)
- 6.1.7 Meiji Holdings Company, Ltd.
- 6.1.8 Global Health Products, Inc.
- 6.1.9 Victus, Inc.
- 6.1.10 Reckitt Benckiser Group plc (Mead Johnson & Company, LLC)
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityOncology Nutrition Industry Segmentation
As per the scope of the report, oncology nutrition is a vital part of the entire process of recovering from cancer. Consuming a wide variety of foods and nutritious meals helps in coping with the heavy medication that is a part of cancer treatment. Following well-balanced oncology, nutrition helps in improving strength, maintaining body weight, and assisting the body in recovering from cancer. The oncology nutrition market is segmented by cancer type (head and neck cancer, stomach and gastrointestinal cancers, blood cancer, breast cancer, lung cancer, and other cancers), end user (hospitals, home care, and others), and geography (North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Cancer Type | Head & Neck Cancer | |
| Stomach & Gastrointestinal Cancers | ||
| Blood Cancer | ||
| Breast Cancer | ||
| Lung Cancer | ||
| Other Cancers | ||
| By End-User | Hospitals | |
| Home Care | ||
| Other End-Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Oncology Nutrition Market Research FAQs
What is the current Oncology Nutrition Market size?
The Oncology Nutrition Market is projected to register a CAGR of 8.90% during the forecast period (2024-2029)
Who are the key players in Oncology Nutrition Market?
Abbott Laboratories, Fresenius Kabi AG, Hormel Foods Corporation (Hormel Health Labs), Nestlé and B. Braun SE are the major companies operating in the Oncology Nutrition Market.
Which is the fastest growing region in Oncology Nutrition Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Oncology Nutrition Market?
In 2024, the North America accounts for the largest market share in Oncology Nutrition Market.
What years does this Oncology Nutrition Market cover?
The report covers the Oncology Nutrition Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Oncology Nutrition Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Oncology Nutrition Industry Report
Statistics for the 2024 Oncology Nutrition market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Oncology Nutrition analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
